MINERVA ENDOCRINOLOGY

Gli articoli più letti nelle ultime tre settimane

Minerva Endocrinology 2021 June;46(2):131-44
Obesity and physical exercise
Ozlem CELIK, Bülent O. YILDIZ *

Minerva Endocrinologica 2019 December;44(4):387-96
Bone health among patients with primary aldosteronism: a systematic review and meta-analysis
Huai H. LOH *, Anne YEE, Huai S. LOH

Minerva Endocrinologica 2018 June;43(2):117-25
Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism
Huai H. LOH, Nor A. KAMARUDDIN, Rozman ZAKARIA, Norlela SUKOR *

Minerva Endocrinologica 2018 December;43(4):476-88
Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding
Elena VORONA, Eberhard NIESCHLAG *

Minerva Endocrinology 2021 June;46(2):168-76
Obesity and GLP-1
Alejandra PEREZ-MONTES DE OCA, Silvia PELLITERO *, Manel PUIG-DOMINGO

Minerva Endocrinologica 2019 September;44(3):273-87
Management of diabetes mellitus in chronic kidney disease
Vishnu GARLA *, Swetha KANDURI, Licy YANES-CARDOZO, Lillian F. LIÉN

Minerva Endocrinologica 2018 March;43(1):11-8
Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy
Yajuan HAN, Min WANG, Jie SHEN, Zhen ZHANG, Min ZHAO, Jing HUANG, Youming CHEN, Zhi CHEN, Yulan HU, Yubing WANG *

Minerva Endocrinologica 2019 December;44(4):333-5
Diabetes mellitus and osteoporosis
Stavroula Α. PASCHOU *, Andromachi VRYONIDOU

Minerva Endocrinologica 2019 December;44(4):363-77
Hyperchloremic normal gap metabolic acidosis
Biff F. PALMER *, Deborah J. CLEGG

Minerva Endocrinologica 2020 June;45(2):127-37
New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists
Luigi BARREA, Gabriella PUGLIESE *, Giovanna MUSCOGIURI, Daniela LAUDISIO, Annamaria COLAO, Silvia SAVASTANO